|
1 De La Fuente-Fernandez R, Stoessl AJ. The placebo effect in Parkinson' s disease. Trends in Neurosciences, 2002, 25 (6): 302-306
2 Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annual Review of Pharmacology and Toxicology, 2008, 48: 33-60
3 Finniss DG, Kaptchuk TJ, Miller F, et al. Biological, clini-cal, and ethical advances of placebo effects. The Lancet, 2010, 375(9715): 686-695
4 Nemoto H, Nemoto Y, Toda H, et al. Placebo analgesia: a PET study. Experimental Brain Research, 2007, 179(4): 655-664
5 Hróbjartsson A, Gφtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treat-ment. New England Journal of Medicine, 2001, 344(21): 1594-1602
6 Vase L, Riley III JL, Price DD. A comparison of placebo eff-ects in clinical analgesic trials versus studies of placebo an-algesia. Pain, 2002, 99(3): 443-452
7 Murray D, Stoessl AJ. Mechanisms and therapeutic implica-tions of the placebo effect in neurological and psychiatric conditions. Pharmacology and Therapeutics, 2013, 140(3): 306-318
8 De la Fuente-Fernández R, Ruth TJ, Sossi V, et al. Expect-ation and dopamine release: mechanism of the placebo effect in Parkinson' s disease. Science, 2001, 293(5532): 1164-1166
9 Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain, 1999, 83(2): 147-156
10 Vase L, Petersen GL, Riley III JL, et al. Factors contributing to large analgesic effects in placebo mechanism studies con-ducted between 2002 and 2007. Pain, 2009, 145(1): 36-44
11 Moseley JB, O'Malley K, Petersen NJ, et al. A controlled tri-al of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine, 2002, 347(2): 81-88
12 Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: Recent advances and current thought. Annual Review of Psychology, 2008, 59: 565-590
13 Hróbjartsson A, Gφtzsche PC. Is the placebo powerless? Up-date of a systematic review with 52 new randomized trials comparing placebo with no treatment. Journal of Internal Medicine, 2004, 256(2): 91-100
14 Petrovic P, Kalso E, Petersson KM, et al. Placebo and opioid analgesia—imaging a shared neuronal network. Science, 2002, 295(5560): 1737-1740
15 Scott DJ, Stohler CS, Egnatuk CM, et al. Individual differen-ces in reward responding explain placebo-induced expecta-tions and effects. Neuron, 2007, 55(2): 325-336
16 Scott DJ, Stohler CS, Egnatuk CM, et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic re-sponses. Archives of General Psychiatry, 2008, 65(2): 220-231
17 Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. American Journal of Psychiatry, 2002, 159(5): 728-737
18 Kaptchuk TJ, Kelley JM, Deykin A, et al. Do“placebo re-sponders”exist? Contemporary Clinical Trials, 2008, 29(4): 587-595
19 Zubieta JK, Bueller JA, Jackson LR, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid recep-tors. Journal of Neuroscience, 2005, 25(34): 7754-7762
20 Morton DL, El-Deredy W, Watson A, et al. Placebo analge-sia as a case of a cognitive style driven by prior expectation. Brain Research, 2010, 1359: 137-141
21 Buhle J, Wager TD. Performance-dependent inhibition of pain by an executive working memory task. Pain, 2010, 149 (1): 19-26
22 Villemure C, Bushnell MC. Mood influences supraspinal pain processing separately from attention. The Journal of Neuroscience, 2009, 29(3): 705-715
23 Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nature Reviews: Neuroscience, 2005, 6(7): 533-544
24 Benedetti F, Amanzio M, Vighetti S, et al. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. The Journal of neuroscience, 2006, 26(46): 12014-12022
25 Meagher MW, Arnau RC, Rhudy JL. Pain and emotion: Eff-ects of affective picture modulation. Psychosomatic Medi-cine, 2001, 63(1): 79-90
26 Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain, 2000, 84(1): 65-75
27 Flaten MA, Aslaksen PM, Lyby PS, et al. The relation of emotions to placebo responses. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2011, 366(1572): 1818-1827
28 杨周, 孟景, Jackson T, 等. 中文版疼痛恐惧问卷Ⅲ的信效度. 中国临床心理学杂志, 2013, 21(5): 768-773
29 Lyby PS, Aslaksen PM, Flaten MA. Is fear of pain related to placebo analgesia? Journal of Psychosomatic Research, 2010, 68(4): 369-377
30 Lyby PS, Aslaksen PM, Flaten MA. Variability in placebo analgesia and the role of fear of pain—an ERP study. Pain, 2011, 152(10): 2405-2412
31 Lyby PS, Forsberg JT, Asli O, et al. Induced fear reduces the effectiveness of a placebo intervention on pain. Pain, 2012, 153(5): 1114-1121
32 Tracey I. Getting the pain you expect: mechanisms of place-bo, nocebo and reappraisal effects in humans. Nature Medi-cine, 2010, 16(11): 1277-1283
33 Benedetti F. Cholecystokinin type A and type B receptors and their modulation of opioid analgesia. Physiology, 1997, 12(6): 263-268
34 Benedetti F, Amanzio M. The neurobiology of placebo anal-gesia: From endogenous opioids to cholecystokinin. Progress in Neurobiology, 1997, 52(2): 109-125
35 Benedetti F, Pollo A, Colloca L. Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? The Journal of Neurosci-ence, 2007, 27(44): 11934-11939
36 Morton DL, Watson A, El-Deredy W, et al. Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain, 2009, 146(1-2): 194-198
37 Geers AL, Helfer SG, Kosbab K, et al. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. Journal of Psychosomatic Research, 2005, 58(2): 121-127
38 Geers AL, Kosbab K, Helfer SG, et al. Further evidence for individual differences in placebo responding: an interaction-ist perspective. Journal of Psychosomatic Research, 2007, 62 (5): 563-570
39 Geers AL, Wellman JA, Fowler SL, et al. Dispositional opti-mism predicts placebo analgesia. The Journal of Pain, 2010, 11(11): 1165-1171
40 Meissner K, Kohls N, Colloca L. Introduction to placebo eff-ects in medicine: mechanisms and clinical implications. Philosophical Transactions of the Royal Society B: Biologi-cal Sciences, 2011, 366(1572): 1783-1789
41 Pecina M, Azhar H, Love TM, et al. Personality trait predic-tors of placebo analgesia and neurobiological correlates. Ne-uropsychopharmacology, 2013, 38(4): 639-646
42 De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phe-nomenon in an experimental setting. Pain, 2002, 96(3): 393-402
43 Levine J, Gordon N, Fields H. The mechanism of placebo analgesia. The Lancet, 1978, 312(8091): 654-657
44 Zhang RR, Zhang WC, Wang JY, et al. The opioid placebo analgesia is mediated exclusively through mu-opioid recep-tor in rat. International Journal of Neuropsychopharmacolo-gy, 2013, 16(4): 849-856
45 Benedetti F, Amanzio M, Rosato R, et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Medicine, 2011, 17(10): 1228-1230
46 Stein N, Sprenger C, Scholz J, et al. White matter integrity of the descending pain modulatory system is associated with in-terindividual differences in placebo analgesia. Pain, 2012, 153(11): 2210-2217
47 Hashmi JA, Baria AT, Baliki MN, et al. Brain networks pre-dicting placebo analgesia in a clinical trial for chronic back pain. Pain, 2012, 153(12): 2393-2402
48 Wager TD, Atlas LY, Leotti LA, et al. Predicting individual differences in placebo analgesia: contributions of brain act-ivity during anticipation and pain experience. Journal of Neuroscience, 2011, 31(2): 439-452
49 Hall KT, Lembo AJ, Kirsch I, et al. Catechol-O-methyltr-ansferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PloS One, 2012, 7(10): e48135
50 Yu R, Gollub RL, Vangel M, et al. Placebo analgesia and re-ward processing: Integrating genetics, personality, and intr-insic brain activity. Human Brain Mapping, 2014, 35(9): 4583-4593
51 Leuchter AF, McCracken JT, Hunter AM, et al. Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depre-ssive Disorder. Journal of Clinical Psychopharmacology, 2009, 29(4): 372-377
52 Furmark T, Appel L, Henningsson S, et al. A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activi ty, and Placebo-Induced Relief from Social Anxiety. Journal of Neuroscience, 2008, 28(49): 13066-13074
53 Guo JY, Wang JY, Luo F. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems. J Psychopharmacol, 2010, 24(10): 1561-1567
54 Nolan TA, Price DD, Caudle RM, et al. Placebo-induced analgesia in an operant pain model in rats. Pain, 2012, 153 (10): 2009-2016
55 Guo JY, Yuan XY, Sui F, et al. Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology, 2011, 217(1) :83-90
|